Gold nanocages: Bioconjugation and their potential use as optical imaging contrast agents

Nano Letters

Volumn 5, Issue 3, 2005, Pages 473-477

  Chen, Jingyi ^a   Saeki, Fusayo ^b   Wiley, Benjamin J ^a   Cang, Hu ^a,b   Cobb, Michael J ^b   Li, Zhi Yuan ^c   Au, Leslie ^a   Zhang, Hui ^d   Kimmey, Michael B ^a   Li, Xingde ^b   Xia, Younan ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

^b University of Washington   (United States)

^c INSTITUTE OF PHYSICS   (China)

^d INSTITUTE FOR SYSTEMS BIOLOGY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GOLD NANOCAGES; MOLAR RATIO; OPTICAL COHERENCE IMAGING (OCT); PHOTOACOUSTIC TOMOGRAPHY;

COHERENT LIGHT; GOLD; IMAGING TECHNIQUES; INFRARED RADIATION; IONIZATION; LIGHT ABSORPTION; LIGHT SCATTERING; SILICA; SOLUTIONS; SURFACE PLASMON RESONANCE; SYNTHESIS (CHEMICAL); TISSUE; TOMOGRAPHY;

NANOSTRUCTURED MATERIALS;

CONTRAST MEDIUM; DIAGNOSTIC AGENT; GOLD; NANOMATERIAL;

ARTICLE; CHEMISTRY; CRYSTALLIZATION; EVALUATION; HUMAN; IMAGE QUALITY; IMMUNOASSAY; MATERIALS TESTING; METHODOLOGY; NEOPLASM; OPTICAL COHERENCE TOMOGRAPHY; PARTICLE SIZE; PATHOLOGY; SURFACE PLASMON RESONANCE; TUMOR CELL LINE; ULTRASTRUCTURE;

CELL LINE, TUMOR; CONTRAST MEDIA; CRYSTALLIZATION; GOLD; HUMANS; IMMUNOASSAY; MATERIALS TESTING; NANOSTRUCTURES; NEOPLASMS; PARTICLE SIZE; PHANTOMS, IMAGING; SURFACE PLASMON RESONANCE; TOMOGRAPHY, OPTICAL COHERENCE;

EID: 20144388113     PISSN: 15306984     EISSN: None     Source Type: Journal    
DOI: 10.1021/nl047950t     Document Type: Article

References (30)

1. Huang, D.; Swanson, E. A.; Lin, C. P.; Schuman, J. S.; Stinson, W. G.; Chang, W.; Hee, M. R.; Flotte, T.; Gregory, K.; Puliafito, C. A.; Fujimoto, J. G. Science 1991, 254, 1178.
2. See, for example, (a) Lee, T. M.; Oldenburg, A. L.; Sitafalwalla, S.; Marks, D. L.; Luo, W.; Toublan, F. J.; Suslick, K. S.; Boppart, S. A. Opt. Lett. 2003, 28, 1546. (b) Xu, C. Y.; Ye, J.; Marks, D. L.; Boppart, S. A. Opt. Lett. 2004, 29, 1647. (c) Yang, C.; Choma, M. A.; Lamb, L. E.; Simon, J. D.; Izatt, J. A. Opt. Lett. 2004, 29, 1396. (d) Wang, R. K.; Elder, J. B. Lasers in Surgery & Medicine 2002, 30, 201. (e) Yang, C.; McGukin, L. E. L.; Simon, J. D.; Choma, M. A.; Applegate, B. E.; Izatt, J. A. Opt. Lett. 2004, 29, 2016.
3. See, for example, (a) Lee, T. M.; Oldenburg, A. L.; Sitafalwalla, S.; Marks, D. L.; Luo, W.; Toublan, F. J.; Suslick, K. S.; Boppart, S. A. Opt. Lett. 2003, 28, 1546. (b) Xu, C. Y.; Ye, J.; Marks, D. L.; Boppart, S. A. Opt. Lett. 2004, 29, 1647. (c) Yang, C.; Choma, M. A.; Lamb, L. E.; Simon, J. D.; Izatt, J. A. Opt. Lett. 2004, 29, 1396. (d) Wang, R. K.; Elder, J. B. Lasers in Surgery & Medicine 2002, 30, 201. (e) Yang, C.; McGukin, L. E. L.; Simon, J. D.; Choma, M. A.; Applegate, B. E.; Izatt, J. A. Opt. Lett. 2004, 29, 2016.
4. See, for example, (a) Lee, T. M.; Oldenburg, A. L.; Sitafalwalla, S.; Marks, D. L.; Luo, W.; Toublan, F. J.; Suslick, K. S.; Boppart, S. A. Opt. Lett. 2003, 28, 1546. (b) Xu, C. Y.; Ye, J.; Marks, D. L.; Boppart, S. A. Opt. Lett. 2004, 29, 1647. (c) Yang, C.; Choma, M. A.; Lamb, L. E.; Simon, J. D.; Izatt, J. A. Opt. Lett. 2004, 29, 1396. (d) Wang, R. K.; Elder, J. B. Lasers in Surgery & Medicine 2002, 30, 201. (e) Yang, C.; McGukin, L. E. L.; Simon, J. D.; Choma, M. A.; Applegate, B. E.; Izatt, J. A. Opt. Lett. 2004, 29, 2016.
5. See, for example, (a) Lee, T. M.; Oldenburg, A. L.; Sitafalwalla, S.; Marks, D. L.; Luo, W.; Toublan, F. J.; Suslick, K. S.; Boppart, S. A. Opt. Lett. 2003, 28, 1546. (b) Xu, C. Y.; Ye, J.; Marks, D. L.; Boppart, S. A. Opt. Lett. 2004, 29, 1647. (c) Yang, C.; Choma, M. A.; Lamb, L. E.; Simon, J. D.; Izatt, J. A. Opt. Lett. 2004, 29, 1396. (d) Wang, R. K.; Elder, J. B. Lasers in Surgery & Medicine 2002, 30, 201. (e) Yang, C.; McGukin, L. E. L.; Simon, J. D.; Choma, M. A.; Applegate, B. E.; Izatt, J. A. Opt. Lett. 2004, 29, 2016.
6. See, for example, (a) Lee, T. M.; Oldenburg, A. L.; Sitafalwalla, S.; Marks, D. L.; Luo, W.; Toublan, F. J.; Suslick, K. S.; Boppart, S. A. Opt. Lett. 2003, 28, 1546. (b) Xu, C. Y.; Ye, J.; Marks, D. L.; Boppart, S. A. Opt. Lett. 2004, 29, 1647. (c) Yang, C.; Choma, M. A.; Lamb, L. E.; Simon, J. D.; Izatt, J. A. Opt. Lett. 2004, 29, 1396. (d) Wang, R. K.; Elder, J. B. Lasers in Surgery & Medicine 2002, 30, 201. (e) Yang, C.; McGukin, L. E. L.; Simon, J. D.; Choma, M. A.; Applegate, B. E.; Izatt, J. A. Opt. Lett. 2004, 29, 2016.
7. (a) Loo, C.; Lin, A.; Hirsch, L.; Lee, M. H.; Barton, J.; Halas, N.; West, J.; Drezek, R. Technol. Cancer Res. Treat. 2004, 3, 33.
8. (b) Wang, Y.; Xie, X.; Wang, X.; Ku, G.; Gill, K. L.; O'Neal, D. P.; Stoica, G.; Wang, L. V. Nano Lett. 2004, 4, 1689.
9. (c) Copland, J. A.; Eghtedari, M.; Popov, V. L.; Kotov, N.; Mamedova, N.; Motamedi, M.; Oraevsky, A. A. Mol. Imaging Biol. 2004, 6, 341.
10. (d) Sokolov, K.; Follen, M.; Aaron, J.; Pavlova, I.; Malpica, A.; Lotan, R.; Richards-Kortum, R. Cancer Res. 2003, 63, 1999.
11. (e) Chen, K.; Liu, Y.; Ameer G.; Backman, V. J. Biomecical Opt. 2005, 10, in press.
12. Hirsch, L. R.; Stafford, R. J.; Bankson, J. A.; Sershen, S. R.; Rivera, B.; Price, R. E.; Hazle, J. D.; Halas, N. J.; West, J. L. Proc. Natl. Acad. Sci. U.S.A. 2003, 100, 13549.
13. (a) Sun, Y.; Xia, Y. J. Am. Chem. Soc. 2004, 126, 3892.
14. (b) Sun, Y.; Mayers, B. T.; Xia, Y. Adv. Mater. 2003, 15, 641.
15. (c) Sun, Y.; Xia, Y. Nano Lett. 2003, 3, 1569.
16. (a) Oldenburg, S. J.; Averitt, R. D.; Westcott, S. L.; Halas, N. J. Chem. Phys. Lett. 1998, 288, 243.
17. (b) West, J. L.; Halas, N. J. Annu. Rev. Biomed. Eng. 2003, 5, 285.
18. (a) Wiley, B.; Sun, Y.; Mayers, B.; Xia, Y. Chem. Eur. J. 2005, 11, 454.
19. (b) Wiley, B.; Herricks, T.; Sun, Y. and Xia, Y. Nano Lett. 2004, 4, 1733.
20. For the nanocube synthesis, 5 mL ethylene glycol (EG, J. T. Baker, 9300-01) was first heated at 149 °C for 8 min under a 0.5 SLPM flow of nitrogen. This was done to quickly remove water. Heating was continued under air for another 52 min. A syringe pump (KDS-200, Stoelting, Wood Dale, IL) then regulated the simultaneous injection of two 3-mL EG solutions into the hot EG at a rate of 45 mL per hour. One of the solutions contained 94 mM silver nitrate (Aldrich, 209139-100G), and the other contained 144 mM poly-(vinyl pyrrolidone) (PVP, M. W.≈55,000, Aldrich, 856568-100G, the concentration was calculated in terms of the repeating unit), and 0.22 mM NaCl (Fisher, S271-500). Magnetic stirring was applied throughout the synthesis. The solution typically turned yellow, orange, and then clear within the first hour after injection. After ∼20 h, the solution became orange-red, indicating the presence of 30-nm silver cubes. At this time the reaction was stopped and the nanocubes were washed with acetone and then water before being dispersed in water for galvanic replacement reaction.
21. Korgel, B. A.; Fitzmaurice, D. Adv. Mater. 1998, 10, 661.
22. (a) Draine, B. T.; Flatau, P. J. J. Opt. Soc. Am. A 1994, 11, 1481.
23. (b) Li, Z. Y.; Gu, B. Y.; Yang, G. Z. Phys. Rev. B 1997, 57, 10883.
24. (c) Sosa, I. O.; Noguez, C.; Barrera, R. G. J. Phys. Chem. B 2003, 107, 6269.
25. (d) Jin, R.; Cao, Y.; Mirkin, C. A.; Kelly, K. L.; Schatz, G.; Zheng, J.-G. Science 2001, 107, 668.
26. Schmitt, J. M.; Knuttel, A.; Bonner, R. F. Appl. Opt. 1993, 32, 6032.
27. Carski, T. R. An Investigator's Brochure, "Indocyanine Green: History Chemistry Pharmacology Indiction Adverse Reactions Investigation and Prognosis"; Becton Dickinson and Company: Hunt Valley, MD, June 24, 1994.
28. (a) Yarden, Y.; Sliwkowski, M. X. Nature 2001, 2, 127.
29. (b) Molina, M. A.; Codony-Servat J.; Albanell, J.; Rojo, F.; Arribas, J.; Basela, J. Cancer Res. 2001, 61, 4744.
30. Hayat, M. A. Colloidal Gold: Principles, Methods and Applications, Academic Press: San Diego, CA, 1989.